Clinical Trials Logo

HPV Vaccine clinical trials

View clinical trials related to HPV Vaccine.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT05291871 Active, not recruiting - HPV Infection Clinical Trials

Immunogenicity of Fractional Dose of the HPV Vaccines

Start date: June 15, 2022
Phase: Phase 4
Study type: Interventional

This randomized phase IV trial compares intramuscular and intradermal fractional dose of bivalent HPV vaccine to fractional dose of nonavalent HPV vaccine among men and women aged 27-45 years in Seattle, Washington. Participants will have immune response assessed at baseline, 4 weeks, 6 months, and 12 months

NCT ID: NCT04982614 Active, not recruiting - Hiv Clinical Trials

HPV Vaccination in HIV Infected and HIV Uninfected Adolescents in Eswatini

Start date: April 1, 2022
Phase: Phase 4
Study type: Interventional

This is a multi-site, open-label non-inferiority study of the 9vHPV vaccine among a population of children, adolescents and young women living with HIV in Eswatini. This protocol seeks to assess immunogenicity of a two-dose 9vHPV vaccine regimen among girls and boys (9-14 years) and young women (15-26 years) living with HIV on antiretroviral therapy versus a three-dose 9vHPV vaccine regimen among HIV uninfected young women (15-26 years) in Eswatini. The secondary objectives include examining the safety profiles of the two-dose 9vHPV regimen in those living with HIV and the three-dose 9vHPV regimen in HIV-uninfected young women, as well as measuring the completion of the vaccination series among those living with HIV and those who are not infected with HIV.

NCT ID: NCT04974619 Active, not recruiting - HPV Clinical Trials

Adaptation Of An HPV Education Resource To Promote HPV Vaccination

Start date: July 23, 2021
Phase:
Study type: Observational

The purpose of the study is to assess Human Papillomavirus (HPV) and HPV vaccination knowledge, awareness, attitudes, health beliefs, and behaviors as well as educational preferences for learning more about HPV and HPV vaccination and to receive feedback on and adapt HPV educational materials for Young Latino Men who have Sex with Men (YLMSM).

NCT ID: NCT04235257 Active, not recruiting - HPV Infection Clinical Trials

Intradermal, Fractional Dose of HPV Vaccines:

Start date: November 1, 2020
Phase: Phase 4
Study type: Interventional

This randomized phase IV trial compares fractional dose of bivalent HPV vaccine to fractional dose of nonavalent HPV vaccine among men and women aged 27-45 years in Seattle, Washington. Participants will have immune response assessed at baseline, 4 weeks, 6 months, 12 months, and 24 months.